These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29170802)

  • 1. Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease.
    Krens LL; Baas JM; Guchelaar HJ; Gelderblom H
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):179-182. PubMed ID: 29170802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer.
    Ketzer S; Schimmel K; Koopman M; Guchelaar HJ
    Clin Pharmacokinet; 2018 Apr; 57(4):455-473. PubMed ID: 28853050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancer.
    Liao MZ; Prenen H; Dutta S; Upreti VV
    Cancer Chemother Pharmacol; 2021 Oct; 88(4):665-672. PubMed ID: 34213592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report.
    Krens LL; Baas JM; de Jong FA; Guchelaar HJ; Gelderblom H
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):429-33. PubMed ID: 24258455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatologic Toxicities: A Chart Review of Clinical Management Among Patients With Metastatic Colorectal Cancer Treated With Panitumumab.
    Lowe KA; Sangaré L; Roehl KA; Jung S; Kafatos G; Garwin T
    Clin J Oncol Nurs; 2019 Apr; 23(2):157-164. PubMed ID: 30880806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.
    Dote S; Itakura S; Kamei K; Hira D; Noda S; Kobayashi Y; Terada T
    BMC Cancer; 2018 Oct; 18(1):957. PubMed ID: 30290786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panitumumab-induced trichomegaly.
    Sütcüoğlu O; Özet A
    Curr Probl Cancer; 2021 Dec; 45(6):100748. PubMed ID: 33933278
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction.
    Krens LL; Baas JM; Verboom MC; Paintaud G; Desvignes C; Guchelaar HJ; Gelderblom H
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1303-6. PubMed ID: 24705976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of oral magnesium-containing supplement and antacid administration on hypomagnesemia induced by panitumumab.
    Sato J; Ishikawa H; Tanaka R; Sino M
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):673-679. PubMed ID: 30661095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation of Actinic Keratosis During Panitumumab Therapy.
    Escudero-Góngora MM; Del Pozo-Hernando LJ; Corral-Magaña O; Antón E
    Actas Dermosifiliogr (Engl Ed); 2018 Oct; 109(8):749-751. PubMed ID: 29187286
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
    Huxley N; Crathorne L; Varley-Campbell J; Tikhonova I; Snowsill T; Briscoe S; Peters J; Bond M; Napier M; Hoyle M
    Health Technol Assess; 2017 Jun; 21(38):1-294. PubMed ID: 28682222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of renal function in patients with colorectal cancer in a gastroenterology clinic of a county hospital in Western Romania.
    Velciov S; Hoinoiu B; Hoinoiu T; Popescu A; Gluhovschi C; Grădinaru O; Popescu M; Moţiu F; Timar R; Gluhovschi GH; Sporea I
    Rom J Intern Med; 2013; 51(3-4):164-71. PubMed ID: 24620629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and grading of EGFR inhibitor-induced cutaneous toxicity.
    Beech J; Germetaki T; Judge M; Paton N; Collins J; Garbutt A; Braun M; Fenwick J; Saunders MP
    Future Oncol; 2018 Oct; 14(24):2531-2541. PubMed ID: 29727211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic meta-analysis of ramucirumab in cancer patients.
    O'Brien L; Westwood P; Gao L; Heathman M
    Br J Clin Pharmacol; 2017 Dec; 83(12):2741-2751. PubMed ID: 28833321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichomegaly Due to Panitumumab.
    Taboada Paz L; Vicente Basanta E; Monteagudo Sánchez B
    JAMA Dermatol; 2024 Jun; 160(6):667. PubMed ID: 38656343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease.
    Albrecht D; Turakhia MP; Ries D; Marbury T; Smith W; Dillon D; Milner PG; Midei MG
    Thromb Haemost; 2017 Nov; 117(11):2026-2033. PubMed ID: 28933798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrichosis of the pinnae in a patient using panitumumab.
    Baykal C; Babuna Kobaner G
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e277-e278. PubMed ID: 29377278
    [No Abstract]   [Full Text] [Related]  

  • 19. Panitumumab: a fully human monoclonal antibody with activity in metastatic colorectal cancer.
    Saadeh CE; Lee HS
    Ann Pharmacother; 2007 Apr; 41(4):606-13. PubMed ID: 17355997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durable complete remission following anti-EGFR antibodies in recurrent metastatic colorectal cancer.
    Boudrias-Dalle E; Cloutier M; Harvey M; Leblanc G; Besner-Morin O; Adam JP
    J Oncol Pharm Pract; 2019 Jan; 25(1):239-243. PubMed ID: 28950807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.